Written Question · S3W-33364 · Session 3
What guidance it has issued to NHS boards regarding the prostate-specific antigen (PSA) test
The question
To ask the Scottish Executive what guidance it has issued to NHS boards regarding the prostate-specific antigen (PSA) test
The answer
Guidance in the form of a Prostate Cancer Risk Management Pack which supports the Prostate Cancer Risk Management Programme was issued to NHS boards (urologists, histopathologists, PSA testing laboratories) and all general practitioners in Scotland. The programme provides guidance to medical practitioners on the situations in which it is suitable to offer PSA testing, the information and guidance that should be provided to patients before PSA testing is undertaken, and the support that may be required by men as they deal with the consequences of the PSA test and any resulting diagnosis.
Details of the programme and copies of the Prostate Cancer Risk Management Pack can be found at http://www.scotland.gov.uk/topics/health/health/cancer/publications.
Details of the programme and copies of the Prostate Cancer Risk Management Pack can be found at http://www.scotland.gov.uk/topics/health/health/cancer/publications.
In the Official Report
No contribution in the Official Report cites S3W-33364 by reference.